Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the biotech industry. This time, you get to discover five hand-picked enzyme technology startups.
Out of 336, the Global Startup Heat Map highlights 5 Top Enzyme Technology Startups
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 336 exemplary startups & scaleups we analyzed for this research. Further, it highlights five biotechnology startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 331 enzyme technology startups, get in touch with us.
Mk2 Biotechnologies facilitates Complex Peptide Biosynthesis
Founding Year: 2020
Location: Munich, Germany
Partner for: Pharmaceuticals
German startup mk2 Biotechnologies creates a biosynthesis production process for complex peptides through recombinant synthesis-based technology. The startup synthesizes different peptides regardless of their physical or chemical properties including chain length, charge, polarity, and hydrophobicity. mk2 Biotechnologies’ novel peptide synthesis technology overcomes the limitations of chemical synthesis that limit its handling of peptides with extreme properties. The peptide solution also finds application as an inhibitor for enzymes or anti-bacterial in the pharmaceutical industries.
Ansa Biotechnologies enables Enzyme-based DNA Synthesis
Founding Year: 2018
Location: Berkeley, USA
Funding: USD 10,2 M
Partner for: Medical Diagnostics
US-based startup Ansa Biotechnologies develops a DNA synthesis method for rapid, clean, and accurate synthesis. The startup uses an enzyme-based process that enables faster, longer, and higher quality DNA synthesis and also allows DNA to be made based on specific requirements at a speed and scale. This overcomes the problems associated with chemical DNA synthesis such as long production times, errors in DNA replications, mispairings between different but non-tautomeric chemical forms of bases, and more. Therefore, Ansa’s technology provides benefits of speed and cost to biological research, therapeutics, and diagnostics applications.
Perseo Pharma offers Therapeutic Enzymes
Founding Year: 2019
Location: Basel, Switzerland
Partner for: Enzyme Replacement Therapy
Swiss startup Perseo Pharma develops an enzyme platform technology using non-therapeutic enzymes. The startup’s highly versatile platform technology called Enzzen allows users to manufacture enzymes with easily tunable size, structure, and property. The Enzzen enzyme is applicable to any enzyme of therapeutic interest. Moreover, the enzymes are immobilized onto safe silica nanoparticles that are shielded with a soft and porous layer of functionalized silica and finished with a fully biocompatible stealth coating. This coating solves some of the key challenges in modern therapeutic enzymes, namely the lack of systemic stability and low residence time.
Revel Pharmaceutical develops Enzyme Therapies for Aging
Founding Year: 2019
Location: San Francisco, USA
Partner for: Enzyme-based Aging Solutions
US-based startup Revel Pharmaceutical develops a proprietary enzyme discovery and engineering engine for patient treatment. The enzymes created through their engine primarily detoxify the chemical damage which accumulates during aging and disease. The startup uses enzymes such as Asparaginase and DNase to repair damage and reverse the course of diseases by addressing toxic chemical byproducts that build up in the body over time. Through its engine, the startup repairs the damage of aging, osteoarthritis, kidney disease, cardiovascular disease, and more at the molecular level, paving the way for efficient enzyme-based therapies.
Zymvol accelerates Molecular Enzyme Modeling
Founding Year: 2017
Location: Barcelona, Spain
Funding: USD 2,2 M
Partner for: Bioinformatics
Spanish startup Zymvol develops molecular modeling software for enzyme discovery and optimization. Its software creates tailor-made enzymes as per the requirement with reliable predictions of their outcomes before development. Additionally, Zymvol’s In Silco search platform accurately identifies enzymes by high-throughput virtual screening and 3D modeling to provide ready-to-use, specialty enzymes for a wide number of applications. Through the startup’s realistic and cloud-based computer simulations of the biocatalytic process, the time required to engineer custom project-specific enzymes is reduced from over a year to within a month.
Discover more BioTech Startups
BioTech startups such as the examples highlighted in this report focus on enzyme therapeutics, modeling, and biosynthesis. While all of these technologies play a major role in advancing the industry, they only represent the tip of the iceberg. To explore BioTech technologies in more detail, simply let us look into your areas of interest. For a more general overview, download our free BioTech Innovation Report to save your time and improve strategic decision-making.